A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases

Authors:

Abstract
No abstract available
Funding Information
  • Roche (4-2012-0166)

This publication has 45 references indexed in Scilit: